Health
NIH to conduct large trial for COVID-19 polyclonal antibody therapies – News-Medical.Net
The National Institutes of Health (NIH) in the USA are to conduct a large-scale clinical trial to evaluate a new fully-human polyclonal antibody therapy targeted…
The National Institutes of Health (NIH) in the USA are to conduct a large-scale clinical trial to evaluate a new fully-human polyclonal antibody therapy targeted at severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative pathogen of coronavirus disease 2019 (COVID-19).
Non-hospitalized people with mild or moderate cases of COVID-19 are to be enrolled at sites around the world, for a test trial called ACTIV-2, which is a part of NIH’s Accelerating COVID-19 Therapeutic Interventions…
-
Noosa News24 hours agoBrisbane’s covert cameras catching more than just litterbugs
-
Business9 hours ago1 ASX dividend stock down 43% I’d buy right now
-
Business13 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?
-
Noosa News9 hours agoExcellence awards nominations received – Proctor